Engineered CAR-T cells expressing CC chemokine receptor 2b (CCR2b) showed improved migration in mesothelioma and neuroblastoma cells expressing CC chemokine ligand L2 (CCL2) [120,121]. Here, CCR2 is linked to neuroblastoma.